Appili Therapeutics: Top 10 Undervalued Healthcare Sector Stocks on TSX (APLI)
Appili Therapeutics is now ranked among the top 10 undervalued stocks in the Healthcare sector on the Toronto Stock Exchange.
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below)
Stocks in this category are held primarily for capital appreciation.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| ACB | Aurora Cannabis | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AIDX | Healwell AI | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AKU | Akumin | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| APLI | Appili Therapeutics | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| APS | Aptose Biosciences | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AVCN | Avicanna | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AVNT | Avant Brands | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| BCT | BriaCell Therapeutics | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| BHC | Bausch Health Companies | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| BLCO | Bausch & Lomb | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 |
All data provided as of December 10, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
Appili Therapeutics
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes programs namely ATI-1701, ATI-1801.
Appili Therapeutics is listed under APLI on the Toronto Stock Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
